-
GEN – Genetic Engineering & Biotechnology News3 months agoNovel Schizophrenia Biomarker and Potential Therapeutic Strategy Identified
Current schizophrenia (SZ) medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms, such as disorganized thinking or executive dysfunction. As a...
-
Fierce Biotech3 months ago
Verily banks $300M to accelerate AI road map, transitions to independent company
Verily raised a $300 million investment round to accelerate its work in artificial intelligence and precision health as it also moves out from under the corporate...
-
BioPharma Dive – AI / Data3 months agoNovo uses FDA voucher to win speedy approval of higher-dose Wegovy
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.
-
Endpoints News3 months ago
Novo wins FDA approval for high-dose Wegovy under commissioner’s voucher
The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to a...
-
Endpoints News3 months ago
Verily raises $300M, sheds Alphabet’s majority control
Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned exclusively....
-
Endpoints News3 months ago
TerraPower’s $450M radioisotope factory; Lilly’s $126M Japan budget
TerraPower Isotopes, a subsidiary of founder Bill Gates’ nuclear company TerraPower, is building an actinium-225 factory in Philadelphia. Production will start in 2029. TerraPower Isotopes said...
-
Fierce Biotech3 months ago
Chutes & Ladders—Eric Topol boards Flagship as advisor
Renowned cardiologist Eric Topol, M.D., is setting sail with Flagship Pioneering as an academic advisor for the firm’s Preemptive Health and Medicine Initiative. Topol is director...
-
AI & Machine Learning in Biotechnology3 months agoSTAT+: Democrats prepare for health care overhaul
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Endpoints News3 months ago
CSL says its hemophilia B gene therapy is out of stock
CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a letter...
-
AI & Machine Learning in Biotechnology3 months agoSTAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries...
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
An obesity drug deep-dive, and peptides move mainstream
